Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : T.ITE: iTech Capital (TSE) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Hamlin who wrote (2892)	12/6/1999 12:59:00 AM
From: David Fedorkiw	Read Replies (1) \| Respond to of 5053

So, what are the pros and cons? On the one hand, we have a stock which is supposed to have a great potential, due mainly to the principles involved with the company, and their connections. They have the medsite deal already, and some would say that this is already priced into the stock. Now we are waiting for more deals to be announced. While we are waiting, some people seem to see that the stock price is weakening and that the prospects, for the near term, don't look great. Those who have sold above $1.40 appear to have made the right choice for now. Those behind this stock appear to have bungled their most recent big news release, and we don't know when to expect more good news. We are getting into the tax loss selling season when some people will be selling their big losers for the year. It sure would be nice if they could be given some reasons for putting what they get into JDX. Or would the company rather wait until the new year for more news? Any opinions? DF